EVENT DETAILS
Wednesday, June 6, 2018
Melville Marriott Long Island
1350 Walt Whitman Road,
Melville, NY 11747
Time
8:00 AM - 5:00 PM
Total Credits
7 Contact Hour(s)
Target Audience
Pharmacist , Pharmacy Technician
Cost
$129.00
Registration closes on 6/5/2018 at 11:00 PM
 

Registration will be held from 8:00 am - 8:30 am. Continental breakfast will be served during this time.

A plated lunch will be served from 12:00 pm - 1:00 pm.

Refreshments will be served during the afternoon programs.

 

AGENDA

Scheduled CE Activities Wednesday, June 6, 2018
  
The purpose of this activity is to educate pharmacists and pharmacy technicians on the epidemiology, risk factors and screening recommendations for Hepatitis C (HCV). Explain the current state of HCV management and the various roles pharmacists have already embarked to facilitate wider progressive development in the pharmacy profession. Through this education session, we will identify the various methods pharmacists can support the eliminate HCV in the United States.
 
 
Pharmacist Learning Objectives
  • Explain the epidemiology, risk factors and screening recommendations for Hepatitis C (HCV)
  • Describe the modern treatment options for HCV
  • Illustrate practical pharmacist and patient interactions for treatment of HCV
  • Identify the various progressive roles pharmacists can incorporate into their current work flow to assist in the elimination of HCV in the United States
Pharmacy Technician Learning Objectives
  • Define Hepatitis C Virus (HCV)
  • Describe the modern treatment options for HCV
 
Faculty
Susan MK LeePharmD, CDE
Specialist Pharmacist, Northwell Health
 
ACPE UAN
0280-9999-18-027-L01-P (Knowledge-Based)
0280-9999-18-027-L01-T (Knowledge-Based)
 
Credits
1.5
 
Handouts
 
Pharmacy has been thrust into the national spotlight as solutions are sought to manage the inappropriate distribution of prescription medications. This session seeks to explore various tools available to the pharmacy staff to combat illicit distribution, while maintaining appropriate and legitimate patient access to prescribed medications. The effectiveness and limitations of state Prescription Drug Monitoring Programs (PDMPs) are discussed in the context of “red flag” behaviors that may suggest inappropriate distribution. The session further seeks to identify current trends in the use and misuse of controlled substances from multiple professional, sociological, and regulatory perspectives.
 
 
Pharmacist Learning Objectives
  • Identify the role, proper use, and limitations of state Prescription Drug Monitoring Programs (PDMPs) in determining appropriate access to controlled substance medications
  • Identify common 'red flags' that should initiate further investigation when considering the validity of a controlled substance prescription, including the assessment of appropriate therapeutic value
  • Describe current trends related to the abuse of prescription drugs
Pharmacy Technician Learning Objectives
  • Identify the role, proper use, and limitations of state Prescription Drug Monitoring Programs (PDMPs) in determining appropriate access to controlled substance medications
  • Identify common 'red flags' that should initiate further investigation when considering the validity of a controlled substance prescription, including the assessment of appropriate therapeutic value
  • Describe current trends related to the abuse of prescription drugs
 
Faculty
Kevin HopeRPh
Clinical Education Specialist and Continuing Education Administrator, PharmCon, Inc.; Advisory Board Member, Paradigm Education Solutions; Nuclear Pharmacist, Triad Isotopes
 
ACPE UAN
0280-0000-18-012-L04-P (Knowledge-Based)
0280-0000-18-012-L04-T (Knowledge-Based)
 
Credits
1.5
 
Handouts
 
Patients with diabetes are also much more likely to suffer from cardiovascular disease than those without diabetes. In fact, cardiovascular disease is the leading cause of death associated with diabetes certainly a medical double jeopardy. The American Diabetes Association’s (ADA) recently published the 2017 Standards of Medical Care in Diabetes and included new recommendations on treating both diabetes and cardiovascular disease. Pharmacists are often the medical professional that patients reach out to for guidance and explanation on new pharmaco-therapy and individualized treatment. This program will review the ADA’s latest update to the Standards of Medical Care in Diabetes, review recent outcomes trials of antihyperglycemic therapies in patients with type 2 diabetes (T2D) and outline evidence based treatment strategies to mitigate the risk of cardiovascular disease in patients with T2D.
 
 
Pharmacist Learning Objectives
  • Summarize the ADA and AACE guidelines with respect to efficacy and safety particularly when analyzing cardiovascular and renal outcomes.
  • Recognize the drug therapies that show evidence of benefit in improving blood sugars and decreasing risk of cardiovascular and renal events.
  • Identify guidelines that are recommended by the ADA and AACE for CV risk reduction and the others in this class.
Pharmacy Technician Learning Objectives
  • Discuss the ADA and AACE guidelines with respect to efficacy and safety of the recommended treatment regimens
  • Recognize potential cardiovascular benefits and risks of various treatment approaches for diabetes
 
Faculty
Regina GinzburgPharmD
Associate Clinical Professor, St. John's University
 
ACPE UAN
0280-0000-18-028-L01-P (Knowledge-Based)
0280-0000-18-028-L01-T (Knowledge-Based)
 
Credits
2
 
Handouts
 
As contemporary healthcare has become more complex, medical errors have been increasingly recognized as a major contributor to the overall morbidity and mortality in the United States.   These errors may occur as the result of human errors or may be the result of failures in our drug-use system.  The major underlying causes of errors that will be addressed in this presentation include errors in perception, confirmation bias, look-alike, sound-alike medications, poor packaging, and the inappropriate use of technology.  In addition, the challenges of providing care in a multi-cultural society will be addressed.  Recommendations for the minimization of such errors will be provided. 
 
 
Pharmacist Learning Objectives
  • Differentiate between human errors and system errors
  • Explain the challenges of providing proper patient care in a multicultural society and describe interventions that can be made to ensure safe and appropriate medication use
  • Identify ways in which the use of technology may increase the risk of error occurrence and how such errors can be minimized
  • Discuss means to improve patient safety and avoid errors secondary to sound-alike, look-alike medications
Pharmacy Technician Learning Objectives
  • Differentiate between human errors and system errors
  • Explain the challenges of providing proper patient care in a multicultural society and describe interventions that can be made to ensure safe and appropriate medication use
  • Identify ways in which the use of technology may increase the risk of error occurrence and how such errors can be minimized
  • Discuss means to improve patient safety and avoid errors secondary to sound-alike, look-alike medications
 
Faculty
Joseph EtzelPharmD
Assistant Dean and Associate Clinical Professor, St Johns University College of Pharmacy
 
ACPE UAN
0280-0000-18-026-L05-P (Knowledge-Based)
0280-0000-18-026-L05-T (Knowledge-Based)
 
Credits
1
 
Handouts
 
State licensure via examination has long been the standard of competence for pharmacists. This session seeks to examine the origins of this regulatory model and to identify the advantages and disadvantages of this model as an assurance of competence. The session further seeks to examine profession driven mechanisms for pharmacists and pharmacy technicians to prove mastery of skill. Finally, the session examines the evolving regulatory state of pharmacy technician competency assessment in the United States.
 
 
Pharmacist Learning Objectives
  • Describe to role of the state board of pharmacy in regard to the assurance of professional competence
  • Identify industry specific modalities of assessing competence in specialty areas of pharmacy practice
  • Describe the variability and challenges in assessing the competence of pharmacy technicians in the United States
Pharmacy Technician Learning Objectives
  • Describe to role of the state board of pharmacy in regard to the assurance of professional competence
  • Identify industry specific modalities of assessing competence in specialty areas of pharmacy practice
  • Describe the variability and challenges in assessing the competence of pharmacy technicians in the United States
 
Faculty
Kevin HopeRPh
Clinical Education Specialist and Continuing Education Administrator, PharmCon, Inc.; Advisory Board Member, Paradigm Education Solutions; Nuclear Pharmacist, Triad Isotopes
 
ACPE UAN
0280-0000-18-013-L03-P (Knowledge-Based)
0280-0000-18-013-L03-T (Knowledge-Based)
 
Credits
1
 
Handouts
 
 
 
 
Requirements for CE Credit
  • Participant Requirement and Statement of Credit: To receive credit, participants must fully attend each session (no partial credit will be awarded), pass in a completed attendance verification form, and using the access code provided, complete the online evaluation for each session attended. Attendance will be verified. All participants will have the opportunity to evaluate the educational sessions and presenters as well as the ability to identify their
  • Pharmacists and Pharmacy Technicians: CE credit will be automatically uploaded to CPE Monitor upon completion of the evaluation and posted to the participant’s NABP account within 72 hours where an official certificate of credit can be printed. Evaluations must be completed within 60 days of program date to receive credit.
  • Statement of Disclosure: Disclosure will be made on the day of the program regarding any interest or affiliation a speaker may have with a supporting organization.
  • Refund Policy: A full refund will be provided only if a written request is received by American Health Resources, LLC at least 48 hours prior to the program or if the program is cancelled. American Health Resources, LLC reserves the right to change the presenters, topics or seminar schedules.
 
Only Certificates of Credit issued from CPE Monitor are valid in the US.
CPE Monitor will not accept credits after 60 days from the session date.
 
Registration closes on 6/5/2018 at 11:00 PM
 

CONTINUING EDUCATION

843 488 5550 Office

843 488 5554 Fax

info@ahrevents.com Email

www.ahrevents.com Web

1404-A Main Street, Conway, SC 29526 Address

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyAmerican Health Resources, LLC a subsidiary of PharmCon, Inc.
Developed By: ITB, Inc.